Oral DDAVP is a Good Alternative Therapy for Patients with Central Diabetes Insipidus: Experience of Five-Year Treatment
Open accessThe DOI matches its Crossref record.
Abstract
We studied the efficacy and safety of oral 1-deamino-8-D-arginine-vasopressin (DDAVP) tablets in 9 patients, aged 17-36 years, with central diabetes insipidus (DI). The tablet contained 100 microg of desmopressin acetate. Maximum plasma concentration was obtained at 90 min after a single oral administration of 100 microg DDAVP with a mean plasma level of 14.7 +/- 5.4 (range: 5.3-50.9) pg/ml. The onset of action was observed 2 h after oral administration, while the maximum effect was obtained at 4 h. Mean urine volume in patients decreased significantly from 402 +/- 52 to 26 +/- 3 ml/hr and urine osmolality increased from 91 +/- 8 to 732 +/- 21 mosm/kg at 4 h after the intake of oral DDAVP. Plasma osmolality level and serum sodium concentration remained unchanged throughout the study. Long-term treatment for 5 years with oral DDAVP resulted in control of diuresis in 8 of the 9 patients. The average oral DDAVP dose required to obtain this control was 19 +/- 2 (range: 15-30) times more than that of prior intranasal treatment. No adverse effects were observed during this follow-up period. These results indicate that oral DDAVP is a safe therapeutic agent that may be a good alternative treatment of central DI, particularly in patients who have chronic rhinitis and visual disturbances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Treatment of Neurohypophyseal Diabetes Insipidus
Oiso, Y., Robertson, G. L., Nørgaard, J. P., & Juul, K. V. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2326 · Cited by 101
“Clinical studies of the pharmacokinetics, pharmacodynamics, efficacy, and safety of oral desmopressin tablets have also been conducted in Japanese and Chinese patients with neurohypophyseal DI (40, 41).”
Desmopressin duration of antidiuretic action in patients with central diabetes insipidus
Juul, K. V., Bichet, D. G., & Nørgaard, J. P. (2011) · Endocrine · doi:10.1007/s12020-011-9492-z · Cited by 26
Metadata
- Authors
- FUKUDA, I., HIZUKA, N., & TAKANO, K.
- Venue
- Endocrine Journal
- Publisher
- Japan Endocrine Society
- Published
- 2003
- Volume
- 50
- Issue
- 4
- Pages
- 437-443
- ISSN
- 0918-8959 (ISSN-L)
- 1348-4540
- OpenAlex
- W2010409345
- Cited by
- 38
- References
- 0
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral DDAVP is a Good Alternative Therapy for Patients with Central Diabetes Insipidus: Experience of Five-Year Treatment. https://app.cochat.ai/papers/10.1507/endocrj.50.437
- The paper
- FUKUDA, I., HIZUKA, N., & TAKANO, K. (2003). Oral DDAVP is a Good Alternative Therapy for Patients with Central Diabetes Insipidus: Experience of Five-Year Treatment. Endocrine Journal. https://doi.org/10.1507/endocrj.50.437
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.